Confocal Laser Endomicroscopy for Bladder Tumor Assessment
Author Information
Author(s): de Ruiter Ben-Max, Freund Jan E., Savci-Heijink C., van Hattum Jons W., Remmelink Marinka J., de Reijke Theo M., Baard Joyce, Kamphuis Guido M., de Bruin D. Martijn, Oddens Jorg R.
Primary Institution: Amsterdam UMC, Amsterdam, The Netherlands
Hypothesis
Can confocal laser endomicroscopy accurately assess the resection bed for bladder tumors?
Conclusion
Confocal laser endomicroscopy is not a reliable tool for detecting residual tumor or detrusor muscle in the resection bed after bladder tumor surgery.
Supporting Evidence
- Confocal laser endomicroscopy was able to predict residual tumor in only 50% of cases identified on histopathology.
- The quality of CLE imaging was low in 18% of cases.
- Histopathology revealed residual tumor in 23% of patients at 3-month follow-up.
Takeaway
The study looked at a special imaging technique to check for leftover cancer in the bladder after surgery, but it wasn't very good at finding it.
Methodology
The study included 40 participants undergoing transurethral resection of bladder tumors, using confocal laser endomicroscopy to assess the resection bed, with histopathology as the reference test.
Potential Biases
Potential sampling bias in resection bed biopsies.
Limitations
High exclusion rate and low prevalence of residual tumors in biopsies.
Participant Demographics
{"median_age":72,"male_percentage":73,"tumor_size_less_than_3cm_percentage":86,"tumor_stage":{"pTa":59,"pT1":14,"pT2":14,"benign":14}}
Statistical Information
Confidence Interval
{"residual_tumor":"95% CI 0.07–0.93","detrusor_muscle":"95% CI 0.39–0.91"}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website